Key result
Circuit reconfiguration resolves differential hypoxemia in peripheral VA-ECMO more effectively than escalating flow.
Why the study?
Differential hypoxemia during peripheral femoro-femoral venoarterial ECMO is a clinically significant yet underexplored presentation that can reduce cerebral and myocardial oxygen delivery. A synthesis of clinical and experimental evidence on its mechanisms, detection, management, and outcomes was needed.
Do configuration-targeted interventions (drainage repositioning, V-AV conversion, proximal arterial return relocation) improve upper-body oxygenation and perfusion in patients developing differential hypoxemia during peripheral VA-ECMO?
Do configuration-targeted interventions (drainage repositioning, V-AV conversion, proximal arterial return relocation) improve upper-body oxygenation and perfusion in patients developing differential hypoxemia during peripheral VA-ECMO?
Differential hypoxemia during peripheral VA-ECMO is a physiology-driven complication that can become refractory to simple ECMO flow escalation as native left ventricular output recovers, making mechanism-based circuit reconfigurations (such as SVC drainage, V-AV conversion, or subclavian return) essential to protect cerebral and coronary perfusion.
Answers are grounded in this paper and cite their sources.
Circuit reconfiguration should supersede flow escalation for differential hypoxemia in peripheral VA-ECMO; extends synthesized evidence on targeted management.
Extracorporeal membrane oxygenation (ECMO) is a widely used technology in cardiac surgery practice. A clinically significant yet underexplored presentation that occurs during peripheral femoro-femoral venoarterial ECMO (VA-ECMO) is differential hypoxemia (DH) or Harlequin syndrome. This phenomenon may occur when the aortic mixing interface shifts distally, and the coronary and supra-aortic circulations receive predominantly hypoxemic native blood. DH may reduce cerebral and myocardial oxygen delivery and produce clinically meaningful arterial partial pressure of carbon dioxide (PaCO2) gradients.This scoping review aimed to synthesize clinical and experimental evidence on the mechanisms, detection, management, and outcomes of DH during peripheral VA-ECMO.A scoping review of the watershed phenomenon during peripheral VA-ECMO was conducted using MEDLINE and EMBASE in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) guidelines. The initial search identified 245 records. After screening, 16 studies were included.DH frequency ranged from 1.5% to 13.3%, but estimates varied substantially across case definitions, diagnostic thresholds, and cohort compositions. Regarding management, configuration-targeted strategies improved surrogates of upper-body oxygenation and perfusion, which included shifting venous drainage toward the superior vena cava/upper right atrium, in turn converting to veno-arteriovenous ECMO with internal jugular return (with flow-splitting control) and relocating arterial return to more proximal/antegrade sites. Detection extended beyond paired upper- and lower-body oximetry/arterial blood gases; reported approaches included contrast-enhanced ultrasound, Doppler mapping, and positional computed tomography angiography (CTA). Experimental models described why DH may persist despite higher ECMO flow as native output increases, and they highlight anatomy- and cannulation-dependent cerebral and coronary vulnerability.DH appears to be a predictable, physiology-driven complication best mitigated by modifying drainage position and/or circuit configuration rather than increasing ECMO flow. To further explore this phenomenon, adopting standardized definitions, investigating bedside localization tools, and conducting prospective comparative studies could be considered.
No takes yet. Share an insight, caveat, or question.
Hasheminia et al. (2026) conducted a review in Differential hypoxemia (Harlequin syndrome) and aortic watershed phenomenon during peripheral venoarterial extracorporeal membrane oxygenation (VA-ECMO) (n=1,249). Peripheral femoro-femoral venoarterial ECMO and configuration-targeted mitigation strategies (venous drainage repositioning to SVC/RA, conversion to V-AV ECMO, arterial return relocation) vs. Standard femoro-femoral VA-ECMO or isolated ECMO flow escalation was evaluated on Frequency of differential hypoxemia (Harlequin syndrome) during peripheral VA-ECMO. Differential hypoxemia occurred in 1.5% to 13.3% of peripheral VA-ECMO patients and was effectively mitigated by modifying venous drainage or circuit configuration rather than escalating ECMO flow.
Synapse has enriched 10 related papers. Consider them for comparative context: